Home / Inspections / 1220144

FDA Inspection 1220144 — University Of Texas MD Anderson Cancer Center

University Of Texas MD Anderson Cancer Center — FEI 1670014

The FDA completed an inspection of University Of Texas MD Anderson Cancer Center on September 22, 2023 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 22, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Houston, TX (United States)

Facility

Other inspections at this facility

  • 1270526 (NAI Thu Sep 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1122418 (NAI Thu Mar 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064728 (NAI Mon Aug 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 960316 (NAI Wed Feb 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 949237 (NAI Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources